A few days ago, I published a story about our friends from HIKU/Tokyo Smoke/Doja/Saxx who, having exited from their last company with a $400m+ acquisition by Canopy Growth Corp…
Growing
Anyone who has played sports knows that pain is part of the process. It’s rough on hobbyists who may lose work, but it’s far worse on professional athletes who…
On April 9, 2019 Chemesis International (CSI.C) announced that it will “produce and distribute its all-natural CBD product line Viverian, in Puerto Rico, through its subsidiary Natural Ventures.” The…
The list of potential buyers was thick. When Ascent Industries (ASNT.C) opened the doors to offers for their recently delicensed Agrima BC cannabis facility and the rights to a…
C21 Investments (CXXI.C) reported USD$5.1 million in unaudited revenue for the two months ending March 31, 2019. This amount is a tally from the company’s Nevada and Oregon operations…
As the market for cannabis products develops, companies in the space will need to find new and innovative ways to cut costs and maximize their profit potential. That means…
For a few years now, I’ve been writing about Maple Leaf Green World (MGW.E), a bad company that has long attempted to look like a cannabis company, in the…
Chemesis International (CSI.C) set to purchase 19.9% of the outstanding common stock of GSRX Industries (GSRX.Q) and gain a foothold in dispensaries across the U.S. GSRX is primarily focused…
Last week, one of 1933 Industries’ (TGIF.C) executives was named a High Time’s Women of Weed honoree alongside 20 other women in the cannabis space making “change, progress, and…
Revenues are quickly becoming the new watermark through which to judge companies in the cannabis space, so Cannabis Life Sciences Holdings (CSE:CLSH.U) is fairly chuffed that their subsidiaries, The…